Cancer cells decorate themselves with the CD47 protein, signaling the immune system to stand down. Whitehead Institute Valhalla Fellow Kipp Weiskopf and colleagues have developed a novel drug screen, pinpointing which cancer therapies — when combined with CD47-blocking antibodies — fare best at rallying the immune system against lung cancer cells.
As part of the Whitehead Institute Board of Directors’ strategy for continuing renewal, three highly regarded Board members will leave those roles this July. Each has made significant contributions to the organization’s ongoing capacity to conduct cutting-edge biomedical research and to train future scientific leaders.
Launched with philanthropic seed funding of $10 million, the Initiative will catalyze development of artificial intelligence-based tools to answer foundational questions about biology and human health.
Axolotls (Ambystoma mexicanum) are a critically endangered species of salamander. They are also highly regenerative. The latest story in our Unusual Labmates series explores these fascinating creatures, what Whitehead Institute researchers are hoping to discover by studying them, and why they are worth preserving in the wild. Click here to view the full multimedia story.
The Whitehead Institute community is remembering, with great fondness and appreciation, Emily Wade. Known to friends and associates as “Paddy,” Wade died this past February at the age of 98. Paddy was a wonderful and accomplished person who was part of the Whitehead community for nearly two decades.
Endowed chairs are generally created through philanthropic gifts from individual donors, organizations, or groups of donors honoring a specific person. The chairs — of which Whitehead Institute currently has five — provide steady, predictable funding to support investigations in Members’ labs.
Brad Wierbowski is a postdoc in Whitehead Institute Member David Bartel’s lab studying the turnover of messenger RNAs. We sat down with Brad to learn more about him and his experiences in and out of the lab.
In this episode of AudioHelicase, we sit down with three Whitehead Institute researchers driving breakthroughs in disease treatment. Join us as we explore some of the toughest challenges they're overcoming to move transformative therapies from the lab bench to your medicine cabinet.
Researchers at Whitehead Institute are zooming in on the molecules of life — DNA, RNA, and proteins — to understand how modifications at a molecular level have a lasting impact on the way organisms grow, develop, survive, and reproduce.